🧬 Target ANGPTL3, Tame the Lipids, Transform the Risk
May 19, 2025•5 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
🧬 New hope for lipid warriors!
Solbinsiran (siRNA) slashed apoB 🩸, TGs 🍟, LDL-C 💔 & liver fat 🫀 in just 205 pts with mixed dyslipidaemia.
Safe ✅ Durable ✅ Quarterly dosing? Maybe ✅
Let’s talk outcomes! 🎯
#PROLONGANG3 #RNAtherapy #CardioTwitter #LipidLowering
For the best experience, listen in Metacast app for iOS or Android